Wellington Management Group
PTCT icon

Wellington Management Group’s PTC Therapeutics PTCT Stock Holding History

Wellington Management Group’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337M Buy
4,128,273
+185,663
+5% +$13.4M 0.06% 285
2026
Q1 		$269M Buy
3,942,610
+75,230
+2% +$5.33M 0.05% 320
2025
Q4 		$294M Sell
3,867,380
-1,051,239
-21% -$76.4M 0.05% 304
2025
Q3 		$302M Buy
4,918,619
+224,481
+5% +$11.7M 0.05% 302
2025
Q2 		$229M Sell
4,694,138
-725,034
-13% -$34.4M 0.04% 326
2025
Q1 		$276M Buy
5,419,172
+632,049
+13% +$31.5M 0.05% 272
2024
Q4 		$216M Sell
4,787,123
-3,105,676
-39% -$133M 0.04% 351
2024
Q3 		$293M Sell
7,892,799
-315,807
-4% -$10.6M 0.05% 309
2024
Q2 		$251M Sell
8,208,606
-692,959
-8% -$22.4M 0.04% 332
2024
Q1 		$259M Sell
8,901,565
-915,038
-9% -$25.6M 0.05% 339
2023
Q4 		$271M Buy
9,816,603
+380,415
+4% +$8.7M 0.05% 332
2023
Q3 		$211M Buy
9,436,188
+2,649,824
+39% +$98.5M 0.04% 357
2023
Q2 		$276M Sell
6,786,364
-211,327
-3% -$10.3M 0.05% 325
2023
Q1 		$339M Sell
6,997,691
-433,216
-6% -$19.8M 0.07% 272
2022
Q4 		$284M Sell
7,430,907
-60,155
-0.8% -$2.5M 0.06% 314
2022
Q3 		$376M Buy
7,491,062
+457,557
+7% +$22.4M 0.08% 238
2022
Q2 		$282M Sell
7,033,505
-1,117,036
-14% -$39.2M 0.06% 290
2022
Q1 		$304M Sell
8,150,541
-4,506
-0.1% -$174K 0.05% 312
2021
Q4 		$325M Sell
8,155,047
-611,780
-7% -$23.4M 0.05% 317
2021
Q3 		$326M Buy
8,766,827
+35,435
+0.4% +$1.46M 0.06% 317
2021
Q2 		$369M Sell
8,731,392
-458,965
-5% -$19.7M 0.06% 295
2021
Q1 		$435M Sell
9,190,357
-148,522
-2% -$8.82M 0.08% 251
2020
Q4 		$570M Sell
9,338,879
-133,857
-1% -$7.89M 0.1% 197
2020
Q3 		$443M Buy
9,472,736
+1,449,037
+18% +$71.3M 0.09% 204
2020
Q2 		$407M Buy
8,023,699
+1,785,531
+29% +$87.7M 0.09% 199
2020
Q1 		$278M Buy
6,238,168
+5,300,979
+566% +$267M 0.07% 237
2019
Q4 		$45M Buy
937,189
+158,341
+20% +$6.73M 0.01% 782
2019
Q3 		$26.3M Sell
778,848
-161,327
-17% -$7.02M 0.01% 893
2019
Q2 		$42.3M Buy
940,175
+26,239
+3% +$1.04M 0.01% 806
2019
Q1 		$34.4M Buy
913,936
+16,087
+2% +$540K 0.01% 861
2018
Q4 		$30.8M Buy
897,849
+15,190
+2% +$546K 0.01% 865
2018
Q3 		$41.5M Sell
882,659
-38,956
-4% -$1.61M 0.01% 865
2018
Q2 		$31.1M Buy
921,615
+104,375
+13% +$3.25M 0.01% 937
2018
Q1 		$22.1M Sell
817,240
-22,127
-3% -$561K 0.01% 1045
2017
Q4 		$14M Sell
839,367
-309,670
-27% -$5.24M ﹤0.01% 1170
2017
Q3 		$23M Buy
1,149,037
+71,835
+7% +$1.41M 0.01% 1007
2017
Q2 		$19.7M Buy
1,077,202
+25,545
+2% +$344K ﹤0.01% 1028
2017
Q1 		$10.3M Sell
1,051,657
-2,504,969
-70% -$30.3M ﹤0.01% 1236
2016
Q4 		$38.8M Sell
3,556,626
-1,091,760
-23% -$11.5M 0.01% 782
2016
Q3 		$65.1M Buy
4,648,386
+49,847
+1% +$405K 0.02% 615
2016
Q2 		$32.3M Sell
4,598,539
-101,194
-2% -$742K 0.01% 794
2016
Q1 		$30.3M Buy
4,699,733
+1,532,712
+48% +$26.6M 0.01% 806
2015
Q4 		$103M Buy
3,167,021
+1,198,425
+61% +$35.3M 0.03% 460
2015
Q3 		$52.6M Sell
1,968,596
-230,010
-10% -$9.84M 0.01% 666
2015
Q2 		$106M Sell
2,198,606
-97,977
-4% -$5.72M 0.03% 474
2015
Q1 		$140M Sell
2,296,583
-36,626
-2% -$2.23M 0.04% 414
2014
Q4 		$121M Sell
2,333,209
-47
-0% -$2.07K 0.03% 448
2014
Q3 		$103M Buy
2,333,256
+818,684
+54% +$25.6M 0.03% 492
2014
Q2 		$39.6M Buy
1,514,572
+57,415
+4% +$1.23M 0.01% 816
2014
Q1 		$38.1M Sell
1,457,157
-12,788
-0.9% -$344K 0.01% 830
2013
Q4 		$24.9M Sell
1,469,945
-226,872
-13% -$3.99M 0.01% 933
2013
Q3 		$36.4M Buy
+1,696,817
New +$29.5M 0.01% 807

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Wellington Management Group's PTCT Position: Q2 2026 in Review

Wellington Management Group increased its PTC Therapeutics (PTCT) stake by 4.7% in Q2 2026, buying an estimated $13.4M and bringing the position to 4,128,273 shares worth $337M. The position accounts for 0.06% of the portfolio, ranked #285.

Wellington Management Group first reported a position in PTCT in Q3 2013 and has held it in 52 quarters since. The position peaked at $570M in Q4 2020. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Wellington Management Group held 4,128,273 shares of PTC Therapeutics worth $337M as of Q2 2026.
  • Wellington Management Group bought 185,663 PTC Therapeutics shares in Q2 2026, an estimated $13.4M.
  • PTC Therapeutics made up 0.06% of Wellington Management Group's portfolio in Q2 2026, its #285 holding.
  • Wellington Management Group first reported a position in PTC Therapeutics in Q3 2013 and has held it in 52 quarters since.
  • Wellington Management Group's PTC Therapeutics position peaked at $570M in Q4 2020.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.